CN106581367A - 一种北虫草润肺片的生产方法 - Google Patents
一种北虫草润肺片的生产方法 Download PDFInfo
- Publication number
- CN106581367A CN106581367A CN201510679104.4A CN201510679104A CN106581367A CN 106581367 A CN106581367 A CN 106581367A CN 201510679104 A CN201510679104 A CN 201510679104A CN 106581367 A CN106581367 A CN 106581367A
- Authority
- CN
- China
- Prior art keywords
- cordyceps militaris
- extract
- lung
- tablets
- production method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 210000004072 lung Anatomy 0.000 claims abstract description 20
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 11
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 11
- 241000218628 Ginkgo Species 0.000 claims description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 229920002261 Corn starch Polymers 0.000 claims description 7
- 239000008120 corn starch Substances 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 abstract description 7
- 239000001301 oxygen Substances 0.000 abstract description 7
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 abstract 1
- 244000185386 Thladiantha grosvenorii Species 0.000 abstract 1
- 231100000481 chemical toxicant Toxicity 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 230000000391 smoking effect Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 3
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- -1 3'-Deoxyadenosine Chemical compound 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种实用价值高、组合效果好的北虫草润肺片的生产方法,使其进入工业化生产。优选北虫草、罗汉果、桔梗、白果、山药、形成合理有效的组合,制成北虫夏润肺片具重要的意义,本发明产品提供抗氧自由基元素和人体必须营养元素,通过结合有毒的化学性物质,增加其溶解性,逐步排出,起到清咽润肺的作用。
Description
技术领域
本发明涉及一种北虫草润肺片的生产方法,属于食品加工技术领域。
背景技术
呼吸系统是人体与外界交流最为频繁的器官,人体通过呼吸道及肺,吸入氧气,排出二氧化碳,实现体内的新陈代谢,而主动或被动吸烟或是大气环境的污染,却会造成人体呼吸系统的损害,一般烟草在燃烧后会产生大量的烟雾及有害物质-尼古丁、焦油等,刺激呼吸道,使多数吸烟者表现出咳嗽、多痰等症状,特别是这些物质进入人体后,形成大量的氧自由基,这些活性的氧自由基是刺激正常细胞癌变的主要途径,从而造成吸烟者肺癌的发病率远远高于非吸烟者,而消除这些体内氧自由基最有效物质是还原性维生素,如V C等,而体内的维生素在还原氧自由基的同时,会使体内维生素缺乏,造成人体抵抗力下降,体质减弱,因此人体不能很好地抵御疾病的侵蚀。
北虫草含有丰富的蛋白质、18种氨基酸、17种微量元素、12种维生素:A、B1、B2、B6、B12、C、D、E等含量均高于其它菇类;罗汉果具有清肺利咽,化痰止咳的作用;桔梗具有宣肺、利咽、祛痰的作用,白果具有敛肺定喘的作用;山药具有益肺止咳作用。
所以选择北虫草、罗汉果、桔梗、白果、山药、形成合理有效的组合,制成北虫草润肺片有重要的意义,本发明产品提供抗氧自由基元素和人体必须营养元素,通过结合有毒的化学性物质,增加其溶解性,逐步排出,而有清咽润肺的作用。
发明内容
本发明的目的是提供一种实用价值高、组合效果好的北虫草润肺片的生产方法,进入工业化生产。
为实现上述目的,本发明所采取的技术方案如下:
一种北虫草润肺片的生产方法,包含如下组分及重量配比::北虫草提取物26~28%,罗汉果提取物20~25%,桔梗提取物10~14%,白果提取物8~12%,山药提取物10~20%,微晶纤维素5~10%,硬脂酸镁5~7%,玉米淀粉5~10%。
一种北虫草润肺片的生产方法,其步骤如下:
(1)北虫草、罗汉果、桔梗、白果、山药分别经水提、浓缩、喷雾干燥后得到提取物;
(2)按照它们的重量比,同辅料微晶纤维素、硬脂酸镁、玉米淀粉混合得到组合物,在压片机上加工成北虫草润肺片;
(3)在GMP条件下经过杀菌、包装、检验、出厂。
本发明北虫草中的有效活性成分包括虫草素、虫草酸、虫草多糖、超氧化物歧化酶等多种生物活性物质。虫草素,即3’-脱氧腺苷,同腺苷作用类似,是一种具有抗菌活性的核苷类物质,对核多聚腺苷酸聚合酶有很强的抑制作用,具有抗病毒、抗菌的活性。虫草酸,即甘露醇,能抑制各种病菌的生长,促进机体的新陈代谢。超氧化物歧化酶,是一种非常重要的抗氧化酶,它可以帮助体内消除过多的自由基,避免细胞受到氧化、老化或破坏,还等抑制病毒、增强免疫功能。虫草多糖具有免疫活性,能明显增强体液与细胞免疫功能,促进抗体和干扰素的产生或抗原体反应。
与现有技术相比,本发明具有如下优点:
(1)本发明采用中西医结合的方式,从吸烟对人体产生伤害的原因入手,针对吸烟产生的各种不良症状;
(2)以北虫草为君药,罗汉果为臣药,桔梗为佐药,白果、山药为使药,从而起到清咽润肺,及时补充人体在吸烟后消除氧自由基的消耗,阻止和抑制尼古丁对神经系统的破坏作用;
(3)从根本上消除吸烟对人体造成的伤害,有效地保护了吸烟者的健康,尤其是那些被动吸烟者食用后,再不会成为吸烟者的健康牺牲者。
(4)本发明产品提供抗氧自由基元素和人体必须营养元素,通过结合有毒的化学性物质,增加其溶解性,逐步排出,而有清咽润肺的作用。
本发明的效果在于:选择北虫草、罗汉果、桔梗、白果、山药,形成合理有效的组合,制成北虫草润肺片有重要的意义,本发明产品提供抗氧自由基元素和人体必须营养元素,通过结合有毒的化学性物质,增加其溶解性,逐步排出,而有清咽润肺的作用。
具体实施方式
实施例1:
本实施例北虫草润肺片包含如下组分及重量配比:北虫草提取物140mg,罗汉果提取物110mg,桔梗提取物60mg,白果提取物50mg,山药提取物60mg,微晶纤维素25mg,硬脂酸镁25mg,玉米淀粉30mg。
1、北虫草、罗汉果、桔梗、白果、山药分别经水提、浓缩、喷雾干燥后得到提取物;
2、上诉重量比是每0.5g/片内的原料,生产1万片,就需要乘以1万倍。加入微晶纤维素、硬脂酸镁、玉米淀粉充分混合。
3、按照它们的重量比,混合、过筛得到组合物,在G M P条件下在压片机上加工成北虫草润肺片,可以单个包装,也可以6-12片/板包装。经过杀菌、包装、检验、出厂。
上述实施例为本发明较佳的实施方式,但本发明的实施方式不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围。
Claims (3)
1.一种北虫草润肺片的生产方法,其特征在于,包含如下组分及重量配比:北虫草提取物26~28%,罗汉果提取物20~25%,桔梗提取物10~14%,白果提取物8~12%,山药提取物10~20%,微晶纤维素5~10%,硬脂酸镁5~7%,玉米淀粉5~10%,混合、过筛得到组合物,在压片机上加工成北虫草润肺片;在GMP条件下经过杀菌、包装、检验、出厂。
2.根据权利要求1所述的一种北虫草润肺片的生产方法,其特征在于:玉米淀粉的细度为120目。
3.根据权利要求1所述的一种北虫草润肺片的生产方法,其特征在于,包含如下组分及重量配比:北虫草提取物140mg,罗汉果提取物110mg,桔梗提取物60mg,白果提取物50mg,山药提取物60mg,微晶纤维素25mg,硬脂酸镁25mg,玉米淀粉30mg。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510679104.4A CN106581367A (zh) | 2015-10-16 | 2015-10-16 | 一种北虫草润肺片的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510679104.4A CN106581367A (zh) | 2015-10-16 | 2015-10-16 | 一种北虫草润肺片的生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106581367A true CN106581367A (zh) | 2017-04-26 |
Family
ID=58554605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510679104.4A Pending CN106581367A (zh) | 2015-10-16 | 2015-10-16 | 一种北虫草润肺片的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106581367A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102028084A (zh) * | 2010-11-24 | 2011-04-27 | 韦俊国 | 清烟糖 |
CN103652840A (zh) * | 2012-09-07 | 2014-03-26 | 江苏学府生物工程有限公司 | 一种北冬虫夏草润肺片的生产方法 |
CN103800647A (zh) * | 2013-12-02 | 2014-05-21 | 青岛蓝图文化传播有限公司市南分公司 | 一种止咳平喘的中药组合物 |
-
2015
- 2015-10-16 CN CN201510679104.4A patent/CN106581367A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102028084A (zh) * | 2010-11-24 | 2011-04-27 | 韦俊国 | 清烟糖 |
CN103652840A (zh) * | 2012-09-07 | 2014-03-26 | 江苏学府生物工程有限公司 | 一种北冬虫夏草润肺片的生产方法 |
CN103800647A (zh) * | 2013-12-02 | 2014-05-21 | 青岛蓝图文化传播有限公司市南分公司 | 一种止咳平喘的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012027882A1 (zh) | 治疗失眠的药物组合物及其制备方法 | |
CN103006892B (zh) | 用于防治猪病毒性疾病的药物组合物、预混料及配合料 | |
CN102357154A (zh) | 一种防治鸡传染性支气管炎的中药组合物及其制备方法 | |
CN102552502A (zh) | 一种用于禽细菌性疾病的中药 | |
CN103652840A (zh) | 一种北冬虫夏草润肺片的生产方法 | |
CN102988874A (zh) | 一种用中药治疗禽气囊炎的新方剂及制备工艺 | |
CN102488882B (zh) | 一种治疗猪呼吸道疾病综合征的复方蜂胶组合物及其制备方法 | |
CN102370972B (zh) | 一种治疗鸡传染性支气管炎的复方中药组合物及其制备方法 | |
CN108523121A (zh) | 一种抗霾清肺的功能性食品及其制备方法 | |
CN102370968B (zh) | 一种治疗鸡传染性喉支气管炎的复方蜂胶组合物及其制备方法 | |
CN106581367A (zh) | 一种北虫草润肺片的生产方法 | |
CN102488881B (zh) | 一种促进猪生长育肥的复方蜂胶组合物及其制备方法 | |
CN104383068A (zh) | 一种高效抗病毒、抑菌的中兽药 | |
CN107308248A (zh) | 一种益于提高畜禽生产性能的中草药复方制剂及其制备方法和使用方法 | |
CN102266438B (zh) | 一种淡水鱼类抗病毒药 | |
CN104905406B (zh) | 含黄酮类化合物香精的烟用嘴棒制备方法及应用 | |
CN105831392A (zh) | 一种猪用饲料添加剂及其饲料 | |
CN104367670A (zh) | 一种用于防治仔猪细菌性肠炎的中药颗粒剂及其制备方法 | |
CN103893240A (zh) | 一种预防和/或治疗雾霾性呼吸系统疾病的组合物 | |
CN107691864A (zh) | 一种用于防治肉鸭流感的1%预混料及其制备方法 | |
CN103933376B (zh) | 一种治疗慢性支气管炎的药物组合物 | |
CN108245630A (zh) | 用于防治猪繁殖与呼吸道综合征的中药组合物、发酵型中药微生态制剂及其制备方法和应用 | |
CN102727669B (zh) | 治疗猪丹毒病的复方蜂胶组合物及其制备方法 | |
CN103099877B (zh) | 用于治疗和预防儿童喘息性疾病的中药组方 | |
CN106668819A (zh) | 一种防治猪高热病的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170426 |